- Home
- LICN
LICN
Lichen China Limited
as 04-16-2025 2:39pm EST
Stocks
| Founded: | 2004 | Country: | China |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | 2023 |
| Target Price: | N/A | AVG Volume (30 days): | 88.4K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 55.10 | EPS Growth: | 36.90 |
| 52 Week Low/High: | $0.04 - $7.55 | Next Earning Date: | 01-01-0001 |
| Revenue: | $41,929,000 | Revenue Growth: | 24.86% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Lichen China Limited News
LICN Breaking Stock News: Dive into LICN Ticker-Specific Updates for Smart Investing
PR Newswire
2 months ago
Lichen China Limited Announces Effective Date of Reverse Stock Split and Name Change
PR Newswire
2 months ago
Lichen China Limited Announces Receipt of Nasdaq Delisting Notice Subject to Hearing Request
Insider Monkey
2 months ago
Lichen China (LICN) Expands AI Reach with Full Acquisition of Bondly
MT Newswires
2 months ago
Lichen China Acquires Remaining 40% Stake in Bondly Enterprises for $5.3 Million
PR Newswire
2 months ago
Lichen China Limited Acquires Remaining Equity in Bondly Enterprises to Strengthen AI Development and Business Integration
GlobeNewswire
3 months ago
Univest Securities, LLC Announces Closing of $3.4 Million Registered Direct Offering for its Client Lichen China Limited (NASDAQ: LICN)
Insider Monkey
3 months ago
Lichen China Limited (LICN) to Integrate DeepSeek AI for Enhanced Financial and Taxation Processing
MT Newswires
3 months ago
Lichen China Launches $3.4 Million Registered Direct Offering
Compare LICN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LICN Lichen China Limited - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.